Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants

ConditionHealhty
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUniversity Hospital, Basel, Switzerland

About this trial

This study investigates whether MDMA may have a pain-reducing effect. The effect of MDMA is compared with a placebo (a substance with no active effect).

In the study, moderate pain will be artificially created in healthy participants using repeated small electrical pulses applied under the skin. At the same time, participants will take MDMA or a placebo by mouth. This allows researchers to compare how MDMA affects the artificially created pain. A total of 20 healthy volunteers will take part in this study.

Eligibility criteria

Qualifiers

Age between 18 and 75 years old

Sufficient understanding of the German language

Understanding of procedures and risks associated with the study

Willing to adhere to the protocol and signing of the consent form

Disqualifiers

Relevant chronic or acute medical condition

Any implanted medical devices (e.g., pacemakers, neurostimulators, or metal prostheses)

Current or previous major psychiatric disorder (e.g. bipolar disorder, schizophrenia), current depression or anxiety disorder.

Psychotic disorder or bipolar disorder in first-degree relatives

Trial design

Treatments tested in this trial

  • MDMA 25 mg
  • MDMA 75 mg
  • MDMA 125 mg
  • Placebo

Treatment groups

20 Participants
are divided into 4 treatment groups